U.S. Machinery Stock News

NasdaqGS:CRNC
NasdaqGS:CRNCSoftware

Cerence (CRNC) Returns To TTM Profitability Testing Bullish Turnaround Narratives

Cerence (CRNC) opened its 2026 financial year with Q1 revenue of US$115.1 million and a basic EPS loss of US$0.12, as the company continued to work through a period of mixed earnings. Over the past few quarters, revenue has moved from US$50.9 million in Q1 2025 to US$60.6 million in Q4 2025 and now US$115.1 million in Q1 2026. Over the same period, basic EPS has ranged from a loss of US$0.57 in Q1 2025 to a loss of US$0.31 in Q4 2025 and the latest Q1 loss of US$0.12, creating an earnings...
NYSE:EQH
NYSE:EQHDiversified Financial

Equitable Holdings Q4 Profit Of US$202 Million Tests Loss-Focused Bear Narratives

Equitable Holdings (EQH) has wrapped up FY 2025 with fourth quarter revenue of about US$3.3 billion, basic EPS of US$0.71 and net income of US$202 million, putting a cleaner quarter at the end of what has been a volatile earnings year. Over the past six quarters, revenue has moved between US$1.4 billion and US$4.6 billion while basic EPS has ranged from a loss of US$4.47 per share to a profit of US$2.80 per share, with trailing twelve month EPS at a loss of US$4.83 per share on revenue of...
NYSE:ZWS
NYSE:ZWSBuilding

Zurn Elkay Water Solutions (ZWS) Margin Improvement Reinforces Bullish Narratives Despite Rich P E

Zurn Elkay Water Solutions (ZWS) has wrapped up FY 2025 with fourth quarter revenue of US$407.2 million and basic EPS of US$0.25, while trailing twelve month revenue sits at US$1.70 billion with EPS of US$1.14. This gives investors a clear read on both the latest quarter and the full year run rate. The company has seen quarterly revenue move from US$370.7 million and EPS of US$0.21 in Q4 2024 to a range between US$388.8 million and US$455.4 million and EPS between US$0.24 and US$0.35 through...
NYSE:HP
NYSE:HPEnergy Services

Helmerich & Payne (HP) EPS Loss In Q1 2026 Tests Profitability Recovery Narratives

Helmerich & Payne (HP) opened Q1 2026 with revenue of about US$1.0 billion and a basic EPS loss of US$0.97, as net income excluding extra items came in at a loss of US$96.7 million. Over the last year, the company has seen quarterly revenue stay around the US$1.0 billion mark while EPS has swung from a profit of US$0.55 in Q1 2025 to losses of US$1.64 in Q3 2025, US$0.58 in Q4 2025, and now US$0.97 in Q1 2026. This sets up a results season in which investors are likely to focus on how quickly...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Selective Insurance Group Insider Buying Aligns With Tighter Board Governance

Selective Insurance Group director increased a personal stake in the company through a recent share purchase. The transaction coincides with board approved amendments to the company’s bylaws on director eligibility and leadership responsibilities. The combination of insider buying and governance updates is drawing attention from existing shareholders and potential investors. Selective Insurance Group, traded as NasdaqGS:SIGI, is drawing fresh interest after this insider move at a share...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Black Hills (BKH) Earnings Growth And 12.6% Margin Reinforce Steady Compounder Narrative

Black Hills reported fourth quarter FY 2025 revenue of US$635.5 million with basic EPS of US$1.39, alongside trailing twelve month revenue of US$2.3 billion and EPS of US$3.99 that reflects steady earnings over the past year. The company has seen revenue move from US$2.1 billion and EPS of US$3.70 on a trailing basis in Q3 FY 2024 to US$2.3 billion and EPS of US$3.99 by Q4 FY 2025. This sets up a story where the key question is how much of that earnings power is repeatable. With a trailing...
NasdaqGS:ORLY
NasdaqGS:ORLYSpecialty Retail

O'Reilly Automotive (ORLY) Same Store Sales Growth Reinforces Steady Bullish Narratives

O'Reilly Automotive (ORLY) has wrapped up FY 2025 with fourth quarter revenue of US$4.4b and basic EPS of US$0.72, alongside trailing 12 month revenue of US$17.8b and EPS of US$2.98 that frame the latest print in a broader context. Over recent quarters, the company has seen revenue range from US$4.1b to US$4.7b and quarterly EPS move between US$0.63 and US$0.86, giving investors a clear view of how sales and earnings have tracked through the year. With net income, EPS and margins all firmly...
NYSE:VLTO
NYSE:VLTOCommercial Services

Veralto (VLTO) Margin Improvement To 17.1% Reinforces Quality Earnings Narratives

Veralto (VLTO) has wrapped up FY 2025 with fourth quarter revenue of US$1,396 million and basic EPS of US$1.02, capping a year in which trailing twelve month revenue reached US$5.5 billion and EPS came in at US$3.79, alongside reported earnings growth of 12.8% over the past year. Over the last six reported quarters, the company has seen revenue move from US$1,314 million in Q3 2024 to US$1,396 million in Q4 2025. Quarterly EPS ranged between US$0.89 and US$1.02 across that period, giving...
NYSE:DOCN
NYSE:DOCNIT

Is DigitalOcean (DOCN) Fairly Priced After Strong One Year Share Price Gains?

If you are wondering whether DigitalOcean Holdings is priced attractively today, this article walks through the numbers behind the stock rather than relying on headlines or hype. The shares recently closed at US$57.66, with returns of 2.7% over the last 7 days, 6.8% over 30 days, 17.7% year to date, and 31.1% over the past year. This gives useful context before comparing that price to underlying value. Recent coverage of DigitalOcean has focused on its position as a cloud platform for...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Technologies (LUMN) Near Breakeven Q4 EPS Challenges Prolonged Loss Narratives

Lumen Technologies (LUMN) FY 2025 earnings snapshot Lumen Technologies (LUMN) closed FY 2025 with fourth quarter revenue of US$3.0 billion and basic EPS of roughly US$0.00, as net income excluding extra items landed at a loss of US$2 million. The company has seen quarterly revenue move from US$3.3 billion and basic EPS of US$0.09 in Q4 2024 to US$3.0 billion and a near breakeven basic EPS in Q4 2025, alongside a trailing twelve month loss of US$1.7 billion on basic EPS of US$1.75. With...
NYSE:USPH
NYSE:USPHHealthcare

Assessing U.S. Physical Therapy’s Valuation After Recent Share Price Momentum

Why U.S. Physical Therapy Is Drawing Fresh Attention U.S. Physical Therapy (USPH) is back on investor radars after a recent share price move, with the stock up around 3% over the past month and roughly 14% in the past 3 months. See our latest analysis for U.S. Physical Therapy. That recent 3 month share price return of 13.81% sits against a one year total shareholder return decline of 1.89% and a 5 year total shareholder return decline of 33.30%, which suggests near term momentum has picked...
NasdaqCM:PLYX
NasdaqCM:PLYXPharmaceuticals

Polaryx Therapeutics (PLYX) Valuation Check After Sharp Single Day Share Price Decline

Polaryx Therapeutics (PLYX) has drawn investor attention after a sharp 28.9% single day share price decline, with the stock closing at US$16. This move comes against a year to date return of negative 54.3%. See our latest analysis for Polaryx Therapeutics. The sharp 28.9% single day share price return decline and the year to date share price return of 54.3% point to fading momentum, suggesting that recent moves reflect shifting risk perception more than steady longer term sentiment. If...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Is It Time To Reassess Waystar Holding (WAY) After The Recent Share Price Slide?

If you are trying to figure out whether Waystar Holding stock now offers value, it helps to step back from the recent share price swings and look at what the current market price might be implying. Over the recent period, the shares closed at US$23.99, with returns of a 13.1% decline over 7 days, a 24.5% decline over 30 days, a 23.5% decline year to date, and a 42.8% decline over 1 year, which may prompt questions about how risk and potential reward are being priced in. These moves sit...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

Weatherford International (WFRD) Margin Slippage To 8.8% Tests Bullish Earnings Narratives

Weatherford International’s FY 2025 Earnings Snapshot Weatherford International (WFRD) closed out FY 2025 with Q4 revenue of US$1.3b and basic EPS of US$1.92, backed by net income of US$138m. The company has seen quarterly revenue range from US$1,193m to US$1,341m across the last six reported periods, while basic EPS has moved between US$1.04 and US$2.14 over the same stretch. This provides a clear view of how the top and bottom lines have tracked through the cycle. With a trailing twelve...
NYSE:GGG
NYSE:GGGMachinery

Graco (GGG) Valuation Check After Q4 Growth, Margin Gains And Upbeat 2026 Sales Outlook

Graco (GGG) is back in focus after its fourth quarter and full year 2025 earnings, where sales, net income, and earnings per share all came in higher than the prior year’s levels. See our latest analysis for Graco. The earnings release and 2026 sales guidance have come alongside a 1-day share price return of 3.14%, adding to a 30-day share price return of 9.66% and a 1-year total shareholder return of 9.69%. Taken together, these figures suggest that momentum has been picking up recently. If...
NasdaqCM:SGMO
NasdaqCM:SGMOBiotechs

Assessing Sangamo Therapeutics (SGMO) Valuation After New Fabry Data Financing Move And Leadership Changes

Clinical and financing moves put Sangamo Therapeutics (SGMO) in focus Sangamo Therapeutics (SGMO) moved into the spotlight after releasing detailed Phase 1/2 STAAR study data for its Fabry gene therapy candidate, alongside a US$25 million follow on equity offering and a change in its finance leadership. See our latest analysis for Sangamo Therapeutics. Against this backdrop of clinical data, financing and leadership change, Sangamo Therapeutics’ share price has been under pressure, with a 30...
NYSE:EMR
NYSE:EMRElectrical

Emerson Electric (EMR) Q1 Margin Improvement Reinforces Bullish Earnings Quality Narrative

Emerson Electric (EMR) opened fiscal 2026 with Q1 revenue of US$4.3b and basic EPS of US$1.08, alongside net income from continuing operations of US$605m. This sets a clear benchmark for how the year is starting to shape up. The company has seen quarterly revenue move between US$4.2b and US$4.9b over the past year, while basic EPS ranged from about US$0.86 to US$1.12. This gives investors a consistent read on earnings power as they track the latest print. With trailing net margin at 12.7% and...
NYSE:AMCR
NYSE:AMCRPackaging

Amcor (AMCR) Margin Compression In Q2 Earnings Tests Bullish Growth Narratives

Amcor (AMCR) has just posted Q2 2026 results with revenue of US$5.4b and net income of US$177m, equal to EPS of US$0.38, putting a fresh marker down for how the packaging group is currently earning its margins. The company has seen quarterly revenue move from US$3.2b in Q2 2025 through US$5.1b in Q4 2025 to US$5.7b in Q1 2026 and now US$5.4b, while EPS has ranged from US$0.56 in Q2 2025 to a small loss in Q4 2025 before landing at US$0.57 in Q1 2026 and US$0.38 this quarter. This sets up a...
NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle (CCI) Offering Value After Multi Year Share Price Decline?

Wondering if Crown Castle is offering value at its current share price, or if it is a value trap? This article walks through what the numbers suggest without the hype. The stock last closed at US$86.11, with a 1.4% gain over the past week, a 2.6% decline over the last month, a 2.9% decline year to date, a 0.8% return over 1 year, a 29.2% decline over 3 years, and a 33.4% decline over 5 years. Recent attention on Crown Castle has been driven by ongoing interest in tower and infrastructure...
NYSE:DAVA
NYSE:DAVAIT

Endava (DAVA) Is Down 15.6% After Conservative Guidance Highlights Slower Growth And Cautious Demand – Has The Bull Case Changed?

In recent days, Endava reiterated its emphasis on complex digital transformation projects while issuing conservative guidance that reflects slower revenue growth and cautious enterprise demand. This shift in tone has prompted a more reserved stance from analysts, who are reassessing the company’s risk profile and longer-term growth narrative. With conservative guidance underscoring slower revenue growth, we’ll now examine how this development reshapes Endava’s broader investment narrative...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

How Portfolio Pruning, Renovations, and Dividends At Sunstone Hotel Investors (SHO) Has Changed Its Investment Story

Over the past year, Sunstone Hotel Investors has benefited from a recovering lodging market, steady dividend growth, and active portfolio reshaping through asset sales and selective acquisitions in high barrier to entry locations. Management’s emphasis on ongoing renovations and asset repositioning to enhance competitive strength, supported by stable business and leisure travel demand, is increasingly central to the company’s long-term investment story. We’ll now examine how Sunstone Hotel...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Assessing Astec Industries (ASTE) Valuation After Strong Recent Share Price Performance

Recent performance snapshot for Astec Industries (ASTE) Astec Industries (ASTE) has drawn fresh attention after a strong run over the past year, with the stock showing positive returns over the past month, past 3 months, and year to date. See our latest analysis for Astec Industries. The recent 7 day share price return of 14.29% and 30 day share price return of 17.73% build on a year to date share price return of 22.03%, while the 1 year total shareholder return of 63.86% contrasts with a...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Is Praxis Precision Medicines (PRAX) Now Pricing In Recent Pipeline Progress And Volatile Share Gains

If you are looking at Praxis Precision Medicines and wondering whether the recent excitement is already in the price, you are not alone. The stock closed at US$303.34, with a 9.5% gain over the last 30 days, a 5.9% return year to date, a 243.8% return over 1 year, a 366.0% return over 3 years, and a 62.0% decline over 5 years. Recent company specific news has kept Praxis in focus for investors and added context to these share price moves. Headlines around its pipeline progress, regulatory...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Is JetBlue Airways (JBLU) Now Attractive After Recent Share Price Rebound?

Wondering if JetBlue Airways at around US$5.96 is a bargain or a value trap? This article walks through what the current price really reflects. The stock has returned 18.3% over the last 7 days and 24.2% over the last 30 days, while the 1 year return is a 2.6% decline and the 5 year return is a 64.2% decline. This mix can change how investors think about both risk and potential reward. Recent coverage has focused on JetBlue's ongoing efforts to reshape its route network and cost base, as...